Storia in 8 fonti

Bank of America spending $250M a year on GLP-1 weight loss drugs

CEO Brian Moynihan says GLP-1 medications now account for roughly 13% of the bank's total annual healthcare spending

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

qz.comStai leggendo5 g fa

Bank of America spending $250M a year on GLP-1 weight loss drugs

Bank of America allocates $250M/year to GLP-1 drugs (13% of healthcare budget) for 211k employees. Corporate GLP-1 adoption signals healthcare cost shifts—tech managers must budget this growing line item as drugmakers expand employer coverage.

originale

Timeline cronologica

mercoledì 5 agosto 2026·cnbc.com
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
mercoledì 5 agosto 2026·qz.com
Bank of America spending $250M a year on GLP-1 weight loss drugs
CEO Brian Moynihan says GLP-1 medications now account for roughly 13% of the bank's total annual healthcare spending

Bank of America spending $250M a year on GLP-1 weight loss drugs

Confronto fonti

Bank of America spending $250M a year on GLP-1 weight loss drugs

Timeline cronologica

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America spending $250M a year on GLP-1 weight loss drugs

Bank of America spends more than $250 million on GLP-1s

Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investm

This bank spends $250M annually on weight-loss drugs for employees

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great…

Bank of America spends more than $250 million on GLP-1s

This bank spends $250M annually on weight-loss drugs for employees

Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investm

Bank of America defiende gastar 250 millones al año en fármacos contra la obesidad para sus trabajadores (y no es el único)

Major bank spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says |…